| Trial ID: | L6454 |
| Source ID: | NCT00558883
|
| Associated Drug: |
Acarbose
|
| Title: |
AI(I)DA Acarbose and the Subclinical Inflammation
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 2 Diabetes Mellitus|Subclinical Inflammation
|
| Interventions: |
DRUG: acarbose
|
| Outcome Measures: |
Primary: effect of treatment of leucocyte count before and after test meal, 20 weeks | Secondary: identification of gene arrays are registered of relevant pharmacodynamic structures and metabolism ways. Histological examinations of bioptats; Blood: hsCRP, PAI1; Lymphocyte subpopulations; blood lipids, plasma glucose fasting and postprandial, 20 weeks
|
| Sponsor/Collaborators: |
Sponsor: GWT-TUD GmbH | Collaborators: Technische Universität Dresden|Diakonissen Krankenhaus Dresden, Germany|University of Regensburg
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE3
|
| Enrollment: |
104
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
|
| Start Date: |
2005-01
|
| Completion Date: |
2007-05
|
| Results First Posted: |
|
| Last Update Posted: |
2008-04-11
|
| Locations: |
GWT-TUD GmbH; Centre for Clinical Studies, Dresden, 01187, Germany
|
| URL: |
https://clinicaltrials.gov/show/NCT00558883
|
